When HbA1c stays high despite multiple medicines, insulin doses keep rising, or blood pressure resists treatment — you need specialist-led stabilisation, not just another prescription.
Persistently high HbA1c, escalating insulin requirements and resistant hypertension often signal underlying insulin resistance and metabolic factors that standard care misses. Adding one more tablet rarely fixes a problem that sits deeper than the last prescription.
Our care is guided by our U.S. endocrinology & obesity-medicine advisor Dr. Ashok Kadambi, MD, FACE, with expertise in insulin resistance, GLP-1–based therapies, medical weight management and evidence-based medication selection aligned to U.S. standards. Meet our specialists.
A structured metabolic review can uncover why control is failing and reset the plan — targeting the root cause instead of stacking more medicines.
Every program follows the same three-stage pathway — comprehensive assessment, personalized intervention, and continuous outcome measurement.
A full metabolic review, insulin-resistance evaluation, blood pressure profiling and a complete medication audit to find why control is failing.
A rationalised medication plan, GLP-1 and modern therapies where appropriate, a weight and lifestyle program and blood pressure optimisation.
HbA1c, blood pressure and weight are tracked over time to confirm targets are met — care guided by results, not assumptions.
Specialist-led stabilisation, aligned with U.S. standards.